Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY) a leading RNAi therapeutics company, announced that management will present a company overview at the JMP Securities Healthcare Conference on Wednesday, September 28, 2011 at 1:30 p.m. ET at The St. Regis New York. A live audio webcast of the presentation will be available on the "Investors" section of the company's website, www.alnylam.com. A replay of the presentation will be available on the Alnylam website within 48 hours after the event.

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.

Read full artical and disclimar at : http://doubleinstocks.com/?p=18677